OTCMKTS:FCPG First China Pharmaceutical Group (FCPG) Stock Price, News & Analysis → Does this make you sick? (From Allegiance Gold) (Ad) Free FCPG Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume15,858 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get First China Pharmaceutical Group alerts: Email Address Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About First China Pharmaceutical Group Stock (OTCMKTS:FCPG)First China Pharmaceutical Group, Inc. operates through its wholly owned subsidiary Kun Ming Xin Yuan Tang Pharmacies Co. Ltd. (XYT) is engaged in drug logistics and distribution in Yunnan Province, China through drug stores, medical clinics and hospitals. XYT is a provincial pharmaceutical distributor that offers approximately 5,000 drugs, of which approximately 1,000 are over-the-counter drugs, approximately 1,000 are prescription drugs, approximately 2,000 are prepared Chinese medicines and approximately 1,000 are supplements. The Company’s short term objective is to broaden its product line from 5,000 products to 30,000 and include significantly more Western medicines as well as traditional Chinese drugs and herbs. By expanding its product line six-fold and offering products at a lower price than major competitors, the Company expects to be able to become its customers’ primary distributor, supplying more than 80% of the pharmaceutical products they require.Read More Ad The Freeport SocietyPOTUS in ‘25 Not Biden/Trump, ButAnd I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning. FCPG Stock News HeadlinesMay 15 at 8:18 AM | msn.comThe Vatican’s Gamble With Beijing Is Costing China’s CatholicsMay 14 at 10:16 PM | msn.comPope Francis’s China GambleMay 14 at 12:15 PM | reuters.comPromoter group to sell stake worth $316 million in India's Cipla, CNBC-TV18 reportsMay 2, 2024 | msn.comPCG ship hit by China water cannon suffers over P2 million in damagesMay 2, 2024 | nytimes.comHamas and Fatah Officials, Longtime Rivals, Met in ChinaApril 24, 2024 | msn.comEU investigates fair access to China's medical device marketApril 16, 2024 | msn.comUS committee finds China is subsidizing American fentanyl crisisApril 16, 2024 | apnews.comHouse panel says China subsidizes fentanyl production to fuel crisis in the United StatesApril 12, 2024 | seatrade-maritime.comAstrid Maersk in China green methanol bunkering firstApril 9, 2024 | reuters.comChina graft watchdog probes official of state-owned supplier of defence gearApril 6, 2024 | yahoo.comPfizer accused of ‘bringing discredit’ on pharmaceutical industry after Covid social media postsMarch 28, 2024 | msn.comChina's Xiaomi to enter cut-throat EV market for the first timeMarch 1, 2024 | msn.comChina’s manufacturing activity contracts for 5th straight month despite policy supportFebruary 20, 2024 | morningstar.comChina Lesso Group Holdings Ltd 02128February 16, 2024 | msn.comPharmaceutical industry: public and private initiatives that are changing the gameJanuary 31, 2024 | msn.comCaixin survey shows China's factory activity expanded for a third month in January, extending divergence with official dataJanuary 4, 2024 | msn.comGlobal pharmaceutical firm Roche selects Malaysia as site for first-in-human clinical trial on experimental immunosuppressant drugDecember 29, 2023 | msn.comPharma firms urged to bring bird flu vaccines to PHDecember 29, 2023 | msn.comCell and gene therapy will be top industry trend for pharma in 2024December 4, 2023 | benzinga.comPioneering health innovations at China Int'l Supply Chain ExpoNovember 29, 2023 | msn.comChina Pharma stock soars 115% on launch update for dry eye disease deviceNovember 26, 2023 | msn.comFocus: Indian drug manufacturers benefit from Big Pharma interest beyond ChinaNovember 24, 2023 | tmcnet.com515 companies, organizations to participate in first China International Supply Chain ExpoNovember 22, 2023 | morningstar.comChina Shineway Pharmaceutical Group LtdOctober 26, 2023 | wsj.comChina Shenghai Group Ltd.See More Headlines Receive FCPG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First China Pharmaceutical Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolOTCMKTS:FCPG CUSIP31948N109 CIK1432254 Webwww.firstchinapharma.com Phone+86-852-21381668FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key Competitors(BVII)OTCMKTS:BVII(CBNR)OTCMKTS:CBNR(DGTC)OTCMKTS:DGTC(DTOR)OTCMKTS:DTOR(EFLO)OTCMKTS:EFLOView All Competitors FCPG Stock Analysis - Frequently Asked Questions What other stocks do shareholders of First China Pharmaceutical Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other First China Pharmaceutical Group investors own include Community Bank System (CBU), Owens & Minor (OMI) and ObsEva (OBSV). How do I buy shares of First China Pharmaceutical Group? Shares of FCPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:FCPG) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Next Industry Being Reshaped By AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First China Pharmaceutical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.